組織アブレーション市場：タイプ、技術、適応症別-2025-2030年の世界予測

組織アブレーション市場は、2023年に194億1,000万米ドルと評価され、2024年には208億7,000万米ドルに達すると予測され、CAGR 7.64%で成長し、2030年には325億米ドルになると予測されています。

組織アブレーションは、異常組織や不要組織の除去や破壊を伴う医療処置であり、多くの場合、高周波、レーザー、マイクロ波、超音波などのエネルギータイプを利用します。この技術は、回復時間や手術のリスクを軽減する低侵襲的なアプローチにより、腫瘍学、心臓病学、皮膚科学など様々な分野で非常に重要です。組織アブレーションの用途は、がん腫瘍、心臓不整脈、子宮筋腫のような良性腫瘍の治療に及ぶ。最終用途には、このような高度医療を提供し、高度なアブレーション技術を必要とする病院、診療所、専門外科センターが含まれます。

組織アブレーションの世界市場は、精度と有効性を高める技術の進歩、革新的な治療法を求める慢性疾患の増加、低侵襲手術への傾向の高まりなど、いくつかの成長要因の影響を受けています。さらに、世界人口の高齢化は、調査手法に合致した治療に対する膨大な潜在的需要を提示しています。ビジネスチャンスは、適応症の拡大や既存技術の改良にあり、それによって多様な医療処置への利用が拡大します。企業は人工知能や機械学習を活用することで、手技の成功率や患者の転帰を高めることができます。

しかし、先進的アブレーション・システムの高価格、これらの手技を実施できる熟練した専門家の不足、製品承認プロセスを遅らせる厳しい規制環境などの課題によって、市場は制約を受けています。さらに新興国は、不十分なヘルスケアインフラなどの障壁に直面しています。

研究開発の余地がある革新的な分野としては、ポータブルで費用対効果の高いアブレーションデバイスの開発、バイオターゲットアブレーション技術、より個別化された治療のための診断とアブレーション機能を組み合わせた統合プラットフォームなどが挙げられます。市場力学はダイナミックであり、急速な技術革新と継続的な研究が特徴です。成長を目指す企業は、価値と有効性を実証するためにヘルスケアプロバイダーとの提携に注力し、アブレーションデバイスの継続的な改良のために研究開発に投資し、従来の方法に対する優位性を利害関係者に啓蒙して採用を促進すべきです。

市場力学：急速に進化する組織アブレーション市場の主要市場インサイトを公開

組織アブレーション市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患と老年人口の流行
  • 技術の進歩とMI手技の増加
  • 腫瘍学的処置における医療レーザーの使用の増加
• 市場抑制要因
  • 厳しい規制
• 市場機会
  • ロボットナビゲーション技術の発展
  • 高度なレーザーアブレーション治療へのアクセスしやすさ
• 市場の課題
  • 熟練した専門家の不足

ポーターの5つの力：組織アブレーション市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：組織アブレーション市場における外部からの影響の把握

外部マクロ環境要因は、組織アブレーション市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析組織アブレーション市場における競合情勢の把握

組織アブレーション市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス組織アブレーション市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、組織アブレーション市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨組織アブレーション市場における成功への道筋を描く

組織アブレーション市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の有病率と高齢者人口
    • 技術の進歩とMI手順の増加
    • 腫瘍学の処置における医療用レーザーの使用の増加
  • 抑制要因
    • 厳格な規制の道
  • 機会
    • ロボットナビゲーション技術の開発
    • 高度なレーザーアブレーション治療へのアクセス
  • 課題
    • 熟練した専門家の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 組織アブレーション市場：タイプ別

• 低侵襲手術
• 開腹手術

第7章 組織アブレーション市場：技術別

• 凍結療法
• 電気アブレーション
• 油圧機械アブレーション
• 光/レーザーアブレーション
• マイクロ波アブレーション
• 高周波アブレーション
• 超音波アブレーション

第8章 組織アブレーション市場適応症別

• 心臓病学
• 美容
• 婦人科
• 腫瘍学
• 眼科
• 泌尿器科

第9章 南北アメリカの組織アブレーション市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の組織アブレーション市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの組織アブレーション市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Alcon Inc.
• Angiodynamics, Inc.
• Atricure, Inc.
• Biosense Webster Inc.
• Boston Scientific Corporation
• C.R Bard Inc.
• Ethicon, Inc.
• Galil Medical, Inc.
• HealthTronics, Inc.
• HS Hospital Service S.P.A
• Johnson & Johnson Services, Inc.
• Medtronic PLC
• Misonix, Inc.
• NeuWave Medical, Inc.
• Olympus Corporation
• Smith & Nephew Plc
• SonaCare Medical LLC
• Stryker Corporation

LIST OF FIGURES

• FIGURE 1. TISSUE ABLATION MARKET RESEARCH PROCESS
• FIGURE 2. TISSUE ABLATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL TISSUE ABLATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL TISSUE ABLATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL TISSUE ABLATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL TISSUE ABLATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL TISSUE ABLATION MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL TISSUE ABLATION MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES TISSUE ABLATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES TISSUE ABLATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. TISSUE ABLATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. TISSUE ABLATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. TISSUE ABLATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL TISSUE ABLATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL TISSUE ABLATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. TISSUE ABLATION MARKET DYNAMICS
• TABLE 7. GLOBAL TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL TISSUE ABLATION MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL TISSUE ABLATION MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL TISSUE ABLATION MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL TISSUE ABLATION MARKET SIZE, BY ELECTRICAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL TISSUE ABLATION MARKET SIZE, BY HYDROMECHANICAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL TISSUE ABLATION MARKET SIZE, BY LIGHT/LASER ABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL TISSUE ABLATION MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL TISSUE ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL TISSUE ABLATION MARKET SIZE, BY ULTRASOUND ABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL TISSUE ABLATION MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL TISSUE ABLATION MARKET SIZE, BY COSMETOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL TISSUE ABLATION MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL TISSUE ABLATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL TISSUE ABLATION MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL TISSUE ABLATION MARKET SIZE, BY UROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 35. CANADA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. CANADA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 37. CANADA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES TISSUE ABLATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 52. CHINA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. CHINA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. CHINA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. INDIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. INDIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. INDONESIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. INDONESIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. JAPAN TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. JAPAN TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. MALAYSIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. MALAYSIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. PHILIPPINES TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. PHILIPPINES TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. SINGAPORE TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. SINGAPORE TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. SOUTH KOREA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. SOUTH KOREA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. TAIWAN TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. TAIWAN TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. THAILAND TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. THAILAND TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. VIETNAM TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. VIETNAM TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 88. EUROPE, MIDDLE EAST & AFRICA TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. DENMARK TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. DENMARK TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. EGYPT TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. EGYPT TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. FINLAND TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. FINLAND TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. FRANCE TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. FRANCE TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. GERMANY TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. GERMANY TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. ISRAEL TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. ISRAEL TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 107. ITALY TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. ITALY TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. ITALY TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NETHERLANDS TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. NETHERLANDS TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. NIGERIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. NIGERIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. NORWAY TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. NORWAY TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 119. POLAND TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. POLAND TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. POLAND TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 122. QATAR TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. QATAR TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. QATAR TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. RUSSIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. RUSSIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SAUDI ARABIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. SAUDI ARABIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH AFRICA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH AFRICA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SPAIN TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. SPAIN TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. SWEDEN TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. SWEDEN TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. SWITZERLAND TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. SWITZERLAND TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. TURKEY TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 145. TURKEY TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. UNITED ARAB EMIRATES TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. UNITED ARAB EMIRATES TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. UNITED KINGDOM TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. UNITED KINGDOM TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 152. TISSUE ABLATION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 153. TISSUE ABLATION MARKET, FPNV POSITIONING MATRIX, 2023

The Tissue Ablation Market was valued at USD 19.41 billion in 2023, expected to reach USD 20.87 billion in 2024, and is projected to grow at a CAGR of 7.64%, to USD 32.50 billion by 2030.

Tissue ablation is a medical procedure that involves the removal or destruction of abnormal or unwanted tissue, often utilizing energy types such as radiofrequency, laser, microwave, or ultrasound. This technique is crucial in various fields, including oncology, cardiology, and dermatology, owing to its minimally invasive approach which reduces recovery time and surgical risks. Applications of tissue ablation span across treatments for cancer tumors, cardiac arrhythmias, and benign growths like fibroids. The end-use scope includes hospitals, clinics, and specialized surgical centers that provide such advanced medical care and require sophisticated ablation technologies.

The global market for tissue ablation is influenced by several growth factors, including technological advancements that enhance precision and efficacy, an increasing prevalence of chronic diseases that demand innovative treatment options, and a growing trend toward minimally invasive surgeries. Moreover, the aging global population presents a vast potential demand for treatments consistent with tissue ablation methodologies. Opportunities lie in expanding indications and improving existing technologies, thereby increasing their use in diverse medical procedures. Companies could leverage artificial intelligence and machine learning to enhance procedural success rates and patient outcomes.

However, the market is constrained by challenges such as high costs of advanced ablation systems, a lack of skilled professionals capable of performing these procedures, and stringent regulatory environments that slow product approval processes. Additionally, emerging economies face barriers like inadequate healthcare infrastructure.

Innovative areas ripe for research include the development of portable and cost-effective ablation devices, bio-targeted ablation techniques, and integrated platforms that combine diagnostic and ablation capabilities for more personalized treatments. The tissue ablation market is dynamic, characterized by rapid technological change and ongoing research. Companies aiming for growth should focus on partnerships with healthcare providers to demonstrate value and efficacy, invest in R&D for the continual improvement of ablation devices, and educate stakeholders on advantages over traditional methods to drive adoption.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tissue Ablation Market

The Tissue Ablation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of chronic diseases and geriatric population
  • Technology advancements and increase in MI procedures
  • Increased use of medical lasers for oncology procedures
• Market Restraints
  • Stringent regulatory path
• Market Opportunities
  • Development in robotic navigation technologies
  • Accessibility to advanced laser ablation treatments
• Market Challenges
  • Dearth of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Tissue Ablation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tissue Ablation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tissue Ablation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tissue Ablation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tissue Ablation Market

A detailed market share analysis in the Tissue Ablation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tissue Ablation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tissue Ablation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Tissue Ablation Market

A strategic analysis of the Tissue Ablation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Tissue Ablation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alcon Inc., Angiodynamics, Inc., Atricure, Inc., Biosense Webster Inc., Boston Scientific Corporation, C.R Bard Inc., Ethicon, Inc., Galil Medical, Inc., HealthTronics, Inc., HS Hospital Service S.P.A, Johnson & Johnson Services, Inc., Medtronic PLC, Misonix, Inc., NeuWave Medical, Inc., Olympus Corporation, Smith & Nephew Plc, SonaCare Medical LLC, and Stryker Corporation.

Market Segmentation & Coverage

This research report categorizes the Tissue Ablation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Minimally Invasive Surgery and Open Surgery.
• Based on Technology, market is studied across Cryoablation, Electrical Ablation, Hydromechanical Ablation, Light/Laser Ablation, Microwave Ablation, Radiofrequency Ablation, and Ultrasound Ablation.
• Based on Indication, market is studied across Cardiology, Cosmetology, Gynecology, Oncology, Ophthalmology, and Urology.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of chronic diseases and geriatric population
    • 5.1.1.2. Technology advancements and increase in MI procedures
    • 5.1.1.3. Increased use of medical lasers for oncology procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulatory path
  • 5.1.3. Opportunities
    • 5.1.3.1. Development in robotic navigation technologies
    • 5.1.3.2. Accessibility to advanced laser ablation treatments
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of skilled professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Tissue Ablation Market, by Type

• 6.1. Introduction
• 6.2. Minimally Invasive Surgery
• 6.3. Open Surgery

7. Tissue Ablation Market, by Technology

• 7.1. Introduction
• 7.2. Cryoablation
• 7.3. Electrical Ablation
• 7.4. Hydromechanical Ablation
• 7.5. Light/Laser Ablation
• 7.6. Microwave Ablation
• 7.7. Radiofrequency Ablation
• 7.8. Ultrasound Ablation

8. Tissue Ablation Market, by Indication

• 8.1. Introduction
• 8.2. Cardiology
• 8.3. Cosmetology
• 8.4. Gynecology
• 8.5. Oncology
• 8.6. Ophthalmology
• 8.7. Urology

9. Americas Tissue Ablation Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Tissue Ablation Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Tissue Ablation Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Alcon Inc.
• 3. Angiodynamics, Inc.
• 4. Atricure, Inc.
• 5. Biosense Webster Inc.
• 6. Boston Scientific Corporation
• 7. C.R Bard Inc.
• 8. Ethicon, Inc.
• 9. Galil Medical, Inc.
• 10. HealthTronics, Inc.
• 11. HS Hospital Service S.P.A
• 12. Johnson & Johnson Services, Inc.
• 13. Medtronic PLC
• 14. Misonix, Inc.
• 15. NeuWave Medical, Inc.
• 16. Olympus Corporation
• 17. Smith & Nephew Plc
• 18. SonaCare Medical LLC
• 19. Stryker Corporation